Skip to content

Clinical trials

Completed Immunoblastic Lymphadenopathy trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Not applicable Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20071
20091
20101
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
Wake Forest University Health Sciences2
Asan Medical Center1
Eastern Cooperative Oncology Group1
Mayo Clinic1
Ohio State University Comprehensive Cancer Center1
Roswell Park Cancer Institute1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy11
Lymphoma, Large B-Cell, Diffuse11
Lymphoma, Large-Cell, Anaplastic11
Burkitt Lymphoma10
Leukemia, Lymphocytic, Chronic, B-Cell10
Lymphoma, Follicular10
Lymphoma, Mantle-Cell10
Lymphoma, B-Cell, Marginal Zone9
Multiple Myeloma9
Mycosis Fungoides9

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.